thanks for the addit. 1-Bil. AS guys Effective

thanks for the addit. 1-Bil. AS guys

Effective October 6, 2014, Amarantus Bioscience Holdings, Inc., a Nevada corporation (the “Company”) entered into an employment agreement with Gerald E. Commissiong pursuant to the employment letter (the “Employment Letter”) attached hereto as Exhibit 10.1. Pursuant to the Employment Letter, Mr. Commissiong will continue to serve as the Company’s President and Chief Executive Officer.

Pursuant to the Employment Letter, Mr. Commissiong shall be entitled to an initial base salary “Base Salary” of $225,000 per year, which shall automatically increase to $337,500 per year upon the Company becoming listed on the NASDAQ Stock Market.

In addition to the Base Salary, Mr. Commisiong shall be eligible for a performance bonus of up to 35% of his Base Salary (addit. $118,125) which shall be based upon certain milestones set by the Company’s Board of Directors in their sole discretion.

The Employment Letter provides for the payment of a signing bonus of $50,000, which payment of which Mr. Commissiong agreed to defer until a later date.

---

is this part of the "financial engineering" package to be paid with no revenue on the books

give me a break Gerald

$225,000/yr. = $18,750/mo.

$337/500/yr. = $28,125/mo...........not including $118,125 bonus

either Gerald has BP or JV Agreements in hand - or he has very bad timing

IMHO, to issue this with no revenue is simply - not good economics and not shareholder respectful

I sure hope Gerald has news on Monday morning...........

hasta leugo